Bottom line: CagriSema could become the go-to option for patients who want more than Ozempic alone can offer, especially those struggling with fatty liver disease or stubborn appetite control
GLP-UP is designed to support metabolic balance, appetite control, blood glucose levels, and overall wellnessall in one convenient daily formula
In many markets, GLP-1s are reimbursed for the indications for which they are approved by the relevant authorities, such as the Food and Drug Administration (FDA) in the US
Seek emergency care for severe or persistent abdominal pain, especially pain that moves toward the back, as it could mean pancreatitis
Its important to communicate regularly with your healthcare provider when you begin semaglutide treatment
In Q1 2026, Eli Lilly's revenue grew 56% to 19.8 billion USD